Xu Yufeng, Qiu Shijie, Shen Zhisen, Chen Jingjing
Department of Otorhinolaryngology-Head and Neck Surgery, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo, China.
Cancer Med. 2025 Mar;14(6):e70834. doi: 10.1002/cam4.70834.
Laryngeal squamous cell carcinoma (LSCC) is one of the most prevalent malignancies of the head and neck region. Circular RNAs (circRNAs) have been found to exhibit abnormal expression patterns in various tumors and play pivotal roles in tumorigenesis and tumor progression.
Functional assays assessed proliferation, migration, and invasion. Mechanistic studies were performed to explore the interaction between circTUBD1 and heterogeneous nuclear ribonucleoprotein K (hnRNPK), as well as its regulation of Cell Cycle and Apoptosis Regulator 1 (CCAR1). In vivo experiments confirmed circTUBD1's role in tumor growth and metastasis.
We discovered that circTUBD1 is significantly upregulated in LSCC and promotes the proliferation, invasion, and migration of LSCC cells. circTUBD1 forms a circRNA-protein complex with hnRNPK and facilitates LSCC progression by regulating CCAR1. Furthermore, in vivo experiments in mice demonstrated that silencing circTUBD1 inhibits the proliferation and metastasis of LSCC.
This study provides evidence that circTUBD1 is a potential tumor marker for LSCC and underscores the therapeutic potential of targeting circTUBD1 in this cancer type.
喉鳞状细胞癌(LSCC)是头颈部最常见的恶性肿瘤之一。环状RNA(circRNAs)已被发现在各种肿瘤中表现出异常表达模式,并在肿瘤发生和肿瘤进展中发挥关键作用。
功能试验评估增殖、迁移和侵袭。进行机制研究以探索circTUBD1与异质核糖核蛋白K(hnRNPK)之间的相互作用,以及其对细胞周期和凋亡调节因子1(CCAR1)的调控。体内实验证实了circTUBD1在肿瘤生长和转移中的作用。
我们发现circTUBD1在LSCC中显著上调,并促进LSCC细胞的增殖、侵袭和迁移。circTUBD1与hnRNPK形成环状RNA-蛋白质复合物,并通过调节CCAR1促进LSCC进展。此外,小鼠体内实验表明,沉默circTUBD1可抑制LSCC的增殖和转移。
本研究提供了证据,证明circTUBD1是LSCC的潜在肿瘤标志物,并强调了针对这种癌症类型靶向circTUBD1的治疗潜力。